This will take effect May 6, 2013
Overview and Clinical Utility:
Effective May 6, 2013, PathGroup will implement the QuantiFERON®-TB (QFT) Gold in-house test. The QuantiFERON®-TB Gold In-Tube assay is an innovative whole-blood test that measures the cell-mediated immune response of tuberculosis (TB) infected individuals.
Click Here to read more.